To The Moon

Innovative drugs surge: Is earnings growth driving a sector value revaluation? Today, Hong Kong-listed innovative drug stocks rallied sharply, with WuXi XDC soaring over 14%, Asymchem jumping 16.83%, and Insilico Medicine rising 12.87%. On the news front, WuXi XDC and Asymchem just released their interim 2026 results. For WuXi XDC, first-half revenue reached RMB 3.701 billion, up 37.0% year-on-year, in line with market expectations; net profit attributable to shareholders was RMB 819 million, up 9.9%; adjusted net profit attributable to shareholders was RMB 1.027 billion, up 37.4%, essentially matching revenue growth and indicating sound earnings quality. Gross margin was 37.0%, up 0.9 percentage points year-on-year. Order backlog remained robust, with unfilled service orders of approximat

Hello. On Monday the chip chain was sold from end to end. $Micron Technology(MU)$ closed down 5.83 per cent at US$910.43, $SanDisk Corp.(SNDK)$ fell 6.45 per cent, $SK hynix(SKHY)$ 4.92 per cent, $Advanced Micro Devices(AMD)$ 3.49 per cent, $Marvell Technology(MRVL)$ 3.27 per cent and $Intel(INTC)$ 3.12 per cent, while the optical name $Applied Optoelectronics(AAOI)$ dropped 13.77 per ce

Gold has staged a powerful rally over the past week. Yesterday, spot gold climbed as much as 1.7%, breaking above $4,680 per ounce and reaching its highest intraday level since mid-May. Gold stocks and related ETFs have also benefited from the rally. Over the past week, Newmont (NEM), ProShares Ultra Gold (UGL), and Agnico Eagle Mines (AEM) have all recorded strong gains.$纽曼矿业(NEM)$$2倍做多黄金ETF-ProShares(UGL)$$伊格尔矿业(AEM)$ So what is driving this latest surge? In my view, there are four main reasons. 1. The U.S. Treasury’s Expansion of Long-Term Bond Buybacks Last week, the U.S. Treasury unexpectedly announced that it wou

Warm Tips: How to Make a Post with a Certain Topic Dear Tigers, Unconsciously, the Q1 of 2022 has gone. Over the past period of time, we have witnessed many historic markets volatile, and the market is still under the anxiety of fast rate hikes and high inflation economic circumstances. While Tiger users keep sharing great comments, analysis articles, videos, etc. on US Market, SG stocks, AU stocks, UK shares, Futures market, Options, Cryptocurrencies, and other assets markets. No wonder we are rewarding great content every week: Till now, our community are lucky to gaining more and more new faces with great experiences in stocks trading . Usually, most Tigers may using Tiger Trade APP to trade and check instant information, also participate community's events for fun as well. If you are u

As gold prices press into historic high territory, global investors face a structural turning point in asset allocation. Driven by persistent central bank demand, expanding sovereign debt, inflation tail-risks, and heightened geopolitical friction, bullion has reaffirmed its role as the premier non-fiat store of value. Ray Dalio, founder of Bridgewater Associates, advocates for a 10% to 15% portfolio allocation to gold as a structural hedge against fiat debasement, monetary disorder, and geopolitical stress. In this article, we would like to share our detailed analysis of whether retail and institutional investors should emulate Dalio’s model, how to execute exposure efficiently, and the critical trade-offs between physical gold vehicles and gold mining equities. 1. Introduction: The Macro

Spot gold pushed above $4,600/oz, reaching its highest level in more than three months as Treasury yields weakened and concerns around U.S. debt and the dollar returned to centre stage. The interesting part isn't just the price. 🇺🇸 Treasury has expanded its long-term bond buyback program 📉 Long-term yields initially dropped 💵 The dollar came under pressure 🥇 Gold and gold miners rallied ₿ Bitcoin also responded strongly Ray Dalio has been warning that rising sovereign debt and currency devaluation could become a major problem — and has argued that roughly 10–15% gold exposure can make sense as a portfolio diversifier. But there's another side. Gold is still recovering from its January record rather than breaking into completely new territory, and a hawkish Fed or hotter inflation data coul